BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 7.62 0.53%

Quarterly report 2024-Q2
added 08-06-2024

report update icon

BioCryst Pharmaceuticals Total Current Liabilities 2011-2024 | BCRX

Annual Total Current Liabilities BioCryst Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
150 M 106 M 104 M 106 M 92.3 M 69.5 M 74.8 M 54.4 M 64.5 M 57.7 M 15.3 M 17.2 M 26.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
150 M 15.3 M 72.1 M